Evans syndrome: clinical perspectives, biological insights and treatment modalities

Evans syndrome: clinical perspectives, biological insights and treatment modalities

José Carlos Jaime-Pérez, Patrizia Elva Aguilar-Calderón, Lorena Salazar-Cavazos, David Gómez-Almaguer Department of Hematology, Internal Medicine Division, Dr José E González University Hospital, School of Medicine of the Universidad...

Full description

Bibliographic Details
Main Authors:	Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Journal of Blood Medicine
Subjects:	Fisher Evans Syndrome Autoimmune cytopenias Low-dose Rituximab IVIG Systemic Lupus Erythematosus HSCT.
Online Access:	https://www.dovepress.com/evans-syndrome-clinical-perspectives-biological-insights-and-treatment-peer-reviewed-article-JBM

Similar Items

Systemic lupus erythematosus combined with Evans syndrome and primary biliary cirrhosis: A rare case
by: Lili Zhang, et al.
Published: (2023-11-01)

Diagnostic dilemma in Evans syndrome
by: Harish Chandra, et al.
Published: (2015-01-01)

Evans’ Syndrome: From Diagnosis to Treatment
by: Sylvain Audia, et al.
Published: (2020-11-01)

Pediatric Evans Syndrome: A 20-year experience from a tertiary center in Brazil
by: Bruna Paccola Blanco, et al.
Published: (2023-04-01)

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
by: O. Capdevila, et al.
Published: (2023-07-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
by: Mieke van Schaik, et al.
Published: (2022-11-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

Relationship of T regulatory cells content, activity and serum autoantibodies level in patients with systemic lupus erythematosus receiving rituximab
by: A V Torgashina
Published: (2009-04-01)

SLE‐associated myelitis successfully treated by rituximab
by: Alireza Khabbazi, et al.
Published: (2022-11-01)

Lupus nephritis - case report of an uncommon succession of therapies
by: Andreea Rovinaru, et al.
Published: (2023-12-01)

Evans syndrome and Graves' Disease: An unusual presentation – A case report
by: Amtoj Singh Lamba, et al.
Published: (2022-01-01)

Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
by: Everton Carlos Siviero do Vale, et al.
Published: (2023-06-01)

Immune dysregulation in Kabuki syndrome: a case report of Evans syndrome and hypogammaglobulinemia
by: Lucia Leonardi, et al.
Published: (2023-06-01)

PROSPECTS FOR ANTI-B-CELL THERAPY IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2018-11-01)

Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunityResearch in context
by: James I. Robinson, et al.
Published: (2022-12-01)

Concurrent severe pulmonary tuberculosis with Evans syndrome: a case report with literature review
by: Xiao-hong Pan, et al.
Published: (2022-06-01)

Post-splenectomy Posterior Reversible Encephalopathy Syndrome in a β-Thalassemia Major child with Evans Syndrome
by: Rekha Thaddanee, et al.
Published: (2023-06-01)

Evans Syndrome as a Possible Complication of Brentuximab Vedotin Therapy for Peripheral T Cell Lymphoma
by: Ruxandra Irimia, et al.
Published: (2023-03-01)

Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study
by: Mikhail Kostik, et al.
Published: (2023-05-01)

Oliver Evans : a chronicle of early American engineering /
by: 208950 Bathe, Greville

PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. L. Nasonov, et al.
Published: (2014-06-01)

Alveolar hemorrhage linked to Evans syndrome
by: Nidhal Belloumi, et al.
Published: (2022-01-01)

Rituximab/IVIG in pemphigus – a 10-year study with a long follow-up
by: Issam Hamadah, et al.
Published: (2019-02-01)

A strange case of Evans syndrome
by: Manuel Monti, et al.
Published: (2013-12-01)

Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study
by: Zhuxin Zhang, et al.
Published: (2023-12-01)

Polyautoimmunity in systemic lupus erythematosus patients: New insights from a cross-sectional study
by: Pedro Santos-Moreno, et al.
Published: (2023-01-01)

Review of Evans (2014) : the language myth: why language is not an instinct
by: LaPolla, Randy J.
Published: (2021)

THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2018-07-01)

THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS
by: A. A. Mesnyankina, et al.
Published: (2017-07-01)

The new pathology: dissecting cellular responses in lupus nephritis
by: Bhandari, A
Published: (2023)

Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
by: Mutali Musa, et al.
Published: (2024-02-01)

The great imitator
by: Cristina Gozzi, et al.
Published: (2014-02-01)

Basophils and Systemic Lupus Erythematosus in Murine Models and Human Patients
by: Kuanysh Dossybayeva, et al.
Published: (2020-09-01)

The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
by: Madhu Ramaswamy, et al.
Published: (2021-10-01)

Male systemic lupus erythematosus, an overlooked diagnosis
by: Maria do Socorro Teixeira Moreira Almeida, et al.
Published: (2011-11-01)

Autoimmune Lymphoproliferative Syndrome (ALPS) in a Boy with Massive Lymphadenopathy
by: Hamid Reza Kianifar, et al.
Published: (2010-09-01)

Risk Factors for Systemic Lupus Erythematosus in Qena University Hospitals
by: Aml A. Abady*, et al.
Published: (2024-01-01)

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review
by: Carla Sans-Pola, et al.
Published: (2023-05-01)

An update on the management of refractory cutaneous lupus erythematosus
by: Alice Verdelli, et al.
Published: (2022-09-01)